Litcius/Paper detail

Molecular and Epidemiological Investigation of Fluconazole-resistant <i>Candida parapsilosis</i>—Georgia, United States, 2021

Elizabeth Misas, Lucy S Witt, Monica M. Farley, Stepy Thomas, Emily N Jenkins, Lalitha Gade, Joyce G. Peterson, A. Restrepo, Scott K. Fridkin, Shawn R. Lockhart, Nancy A. Chow, Meghan Lyman

2024Open Forum Infectious Diseases20 citationsDOIOpen Access PDF

Abstract

Abstract Background Reports of fluconazole-resistant Candida parapsilosis bloodstream infections are increasing. We describe a cluster of fluconazole-resistant C parapsilosis bloodstream infections identified in 2021 on routine surveillance by the Georgia Emerging Infections Program in conjunction with the Centers for Disease Control and Prevention. Methods Whole-genome sequencing was used to analyze C parapsilosis bloodstream infections isolates. Epidemiological data were obtained from medical records. A social network analysis was conducted using Georgia Hospital Discharge Data. Results Twenty fluconazole-resistant isolates were identified in 2021, representing the largest proportion (34%) of fluconazole-resistant C parapsilosis bloodstream infections identified in Georgia since surveillance began in 2008. All resistant isolates were closely genetically related and contained the Y132F mutation in the ERG11 gene. Patients with fluconazole-resistant isolates were more likely to have resided at long-term acute care hospitals compared with patients with susceptible isolates (P = .01). There was a trend toward increased mechanical ventilation and prior azole use in patients with fluconazole-resistant isolates. Social network analysis revealed that patients with fluconazole-resistant isolates interfaced with a distinct set of healthcare facilities centered around 2 long-term acute care hospitals compared with patients with susceptible isolates. Conclusions Whole-genome sequencing results showing that fluconazole-resistant C parapsilosis isolates from Georgia surveillance demonstrated low genetic diversity compared with susceptible isolates and their association with a facility network centered around 2 long-term acute care hospitals suggests clonal spread of fluconazole-resistant C parapsilosis. Further studies are needed to better understand the sudden emergence and transmission of fluconazole-resistant C parapsilosis.

Topics & Concepts

FluconazoleCandida parapsilosisGenotypingEpidemiologyMedicineCandida aurisMolecular epidemiologyMicrobiologyBiologyGenotypeInternal medicineCandida albicansAntifungalGeneGeneticsAntifungal resistance and susceptibilityFungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatment
Molecular and Epidemiological Investigation of Fluconazole-resistant <i>Candida parapsilosis</i>—Georgia, United States, 2021 | Litcius